Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Issue 5 (May 2017) - Orgel, Ryan; Wojdyla, Daniel; Huberman, David; Halperin, Jonathan L.; Breithardt, Günter; Singer, Daniel E.; Fox, Keith A.A.; Hankey, Graeme J.; Mahaffey, Kenneth W.; Jones, W. Schuyler; Patel, Manesh R.